ZA993081B - Novel aqueous process for manufacturing paroxetine solid dispersions. - Google Patents
Novel aqueous process for manufacturing paroxetine solid dispersions.Info
- Publication number
- ZA993081B ZA993081B ZA9903081A ZA993081A ZA993081B ZA 993081 B ZA993081 B ZA 993081B ZA 9903081 A ZA9903081 A ZA 9903081A ZA 993081 A ZA993081 A ZA 993081A ZA 993081 B ZA993081 B ZA 993081B
- Authority
- ZA
- South Africa
- Prior art keywords
- paroxetine
- solid dispersions
- amorphous
- aqueous process
- novel aqueous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/074,355 US6168805B1 (en) | 1998-05-07 | 1998-05-07 | Aqueous process for manufacturing paroxetine solid dispersions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA993081B true ZA993081B (en) | 1999-11-05 |
Family
ID=22119113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9903081A ZA993081B (en) | 1998-05-07 | 1999-05-04 | Novel aqueous process for manufacturing paroxetine solid dispersions. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6168805B1 (fr) |
| EP (1) | EP1075263B1 (fr) |
| JP (1) | JP2002513760A (fr) |
| KR (1) | KR20010043418A (fr) |
| CN (1) | CN1115149C (fr) |
| AT (1) | ATE235240T1 (fr) |
| AU (1) | AU3787699A (fr) |
| CA (1) | CA2331288C (fr) |
| DE (1) | DE69906269T2 (fr) |
| ES (1) | ES2196803T3 (fr) |
| HK (1) | HK1038699B (fr) |
| MX (1) | MXPA00010928A (fr) |
| WO (1) | WO1999056751A1 (fr) |
| ZA (1) | ZA993081B (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548084B2 (en) * | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
| US6699882B2 (en) | 1998-03-24 | 2004-03-02 | Smithkline Beecham P.L.C. | Paroxetine compositions |
| US6503927B1 (en) * | 1999-10-28 | 2003-01-07 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
| DE10000792A1 (de) * | 2000-01-11 | 2001-07-19 | Bernhard C Lippold | Formulierungen von Wirkstoffen in Form einer festen Dispersion |
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| US6660298B1 (en) * | 2000-07-27 | 2003-12-09 | Pentech Pharmaceuticals, Inc. | Paroxetine tablets and capsules |
| US6720003B2 (en) * | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
| WO2002085360A1 (fr) * | 2001-04-25 | 2002-10-31 | Pentech Pharmaceuticals, Inc. | Procedures optimisees pour la fabrication de sels de paroxetine |
| WO2002100382A2 (fr) * | 2001-06-08 | 2002-12-19 | Endo Pharmaceuticals, Inc. | Formes posologiques a liberation controlee utilisant un polymere acrylique, et leur procede d'obtention |
| CA2456233A1 (fr) * | 2001-08-02 | 2003-03-13 | Spurcourt Limited | Sel d'isethionate de paroxetine, procede de preparation et utilisation dans le traitement de la depression |
| GB0119467D0 (en) * | 2001-08-09 | 2001-10-03 | Smithkline Beecham Plc | Novel compound |
| IL162666A0 (en) * | 2001-12-28 | 2005-11-20 | Teva Pharma | A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof |
| WO2005107716A1 (fr) * | 2004-03-25 | 2005-11-17 | Cadila Healthcare Limited | Comprimes a liberation lente a base de paroxetine comprenant un noyau et un revetement |
| US20050266082A1 (en) * | 2004-05-26 | 2005-12-01 | Patel Satishkumar A | Preparation of stable paroxetine HC1 ER tablets using a melt granulation process |
| DE102005026755A1 (de) * | 2005-06-09 | 2006-12-14 | Basf Ag | Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung |
| AU2006274565B2 (en) * | 2005-08-02 | 2012-05-17 | Lupin Limited | Novel controlled release compositions of selective serotonin reuptake inhibitors |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| EP1948646A2 (fr) * | 2005-11-14 | 2008-07-30 | Auspex Pharmaceuticals Inc. | Phenylpiperidines substituees a activite serotoninergique et proprietes therapeutiques ameliorees |
| US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
| CN101573030B (zh) * | 2006-12-01 | 2015-01-28 | 巴斯夫欧洲公司 | 通过短期过热和快速干燥制备农药固溶体的方法 |
| CN101909600A (zh) * | 2007-11-09 | 2010-12-08 | 英特维特国际股份有限公司 | 速释固体制剂、其制备及其应用 |
| JP2011503073A (ja) | 2007-11-13 | 2011-01-27 | メリテイジ ファーマ，インク． | コルチコステロイド組成物 |
| US9138430B2 (en) * | 2007-12-27 | 2015-09-22 | Mylan Specialty L.P. | Formulation and method for the release of paroxetine in the large intestine |
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
| WO2010144865A2 (fr) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Procédés de traitement de troubles gastro-intestinaux |
| CN107802603B (zh) * | 2017-12-14 | 2021-08-20 | 乐普制药科技有限公司 | 一种纳普醚醇分散体及其制备方法 |
| CN110037995B (zh) * | 2019-04-17 | 2021-07-06 | 石家庄龙泽制药股份有限公司 | 一种稳定的盐酸帕罗西汀片剂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9325644D0 (en) | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
| US5597826A (en) | 1994-09-14 | 1997-01-28 | Pfizer Inc. | Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
| CA2206592A1 (fr) | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Methode de preparation de chlorhydrate de paroxetine amorphe |
| TR199901622T2 (xx) | 1997-01-15 | 1999-09-21 | Smithkline Beecham Plc | Paroksetin terkipleri. |
| US5955475A (en) | 1997-06-30 | 1999-09-21 | Endo Pharmaceuticals Inc. | Process for manufacturing paroxetine solid dispersions |
-
1998
- 1998-05-07 US US09/074,355 patent/US6168805B1/en not_active Expired - Fee Related
-
1999
- 1999-05-04 ZA ZA9903081A patent/ZA993081B/xx unknown
- 1999-05-05 CN CN99807123A patent/CN1115149C/zh not_active Expired - Fee Related
- 1999-05-05 WO PCT/US1999/009835 patent/WO1999056751A1/fr not_active Application Discontinuation
- 1999-05-05 AT AT99920358T patent/ATE235240T1/de not_active IP Right Cessation
- 1999-05-05 KR KR1020007012453A patent/KR20010043418A/ko not_active Application Discontinuation
- 1999-05-05 EP EP99920358A patent/EP1075263B1/fr not_active Expired - Lifetime
- 1999-05-05 CA CA002331288A patent/CA2331288C/fr not_active Expired - Fee Related
- 1999-05-05 ES ES99920358T patent/ES2196803T3/es not_active Expired - Lifetime
- 1999-05-05 DE DE69906269T patent/DE69906269T2/de not_active Expired - Fee Related
- 1999-05-05 AU AU37876/99A patent/AU3787699A/en not_active Abandoned
- 1999-05-05 MX MXPA00010928A patent/MXPA00010928A/es unknown
- 1999-05-05 JP JP2000546776A patent/JP2002513760A/ja active Pending
-
2002
- 2002-01-15 HK HK02100281.6A patent/HK1038699B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1038699A1 (en) | 2002-03-28 |
| EP1075263A1 (fr) | 2001-02-14 |
| CN1304308A (zh) | 2001-07-18 |
| HK1038699B (zh) | 2003-12-12 |
| EP1075263B1 (fr) | 2003-03-26 |
| JP2002513760A (ja) | 2002-05-14 |
| WO1999056751A1 (fr) | 1999-11-11 |
| US6168805B1 (en) | 2001-01-02 |
| ATE235240T1 (de) | 2003-04-15 |
| CN1115149C (zh) | 2003-07-23 |
| DE69906269D1 (de) | 2003-04-30 |
| MXPA00010928A (es) | 2005-06-06 |
| AU3787699A (en) | 1999-11-23 |
| CA2331288A1 (fr) | 1999-11-11 |
| CA2331288C (fr) | 2007-01-23 |
| ES2196803T3 (es) | 2003-12-16 |
| KR20010043418A (ko) | 2001-05-25 |
| DE69906269T2 (de) | 2004-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA993081B (en) | Novel aqueous process for manufacturing paroxetine solid dispersions. | |
| EG24142A (en) | Crystalline monohydrate, process for the preparation thereof and the use thereof for preparing a pharmaceutical composition | |
| EA199800775A1 (ru) | Таблетки, содержащие бетта-лактамный антибиотик, и способ их изготовления | |
| YU38802A (sh) | Nova kompozicija i njena upotreba | |
| ZA200000169B (en) | Process for the preparation of pellets with a content of up to 90 wt.% of a pharmaceutical active ingredient. | |
| MY122391A (en) | Piperazine derivatives as 5-ht1b antagonists | |
| EA200001201A2 (ru) | Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем | |
| NZ515339A (en) | Use of macrolide compounds for the treatment of dry eye | |
| WO2005034861A3 (fr) | Composition biotherapeutique sechee, ses utilisations et son dispositif et ses procedes d'administration | |
| CA2290893A1 (fr) | Omeprazole de magnesium | |
| DK1171101T3 (da) | Fremgangsmåde til fremstilling af en vanduoplöselig amorf depotmatrix | |
| AU3483497A (en) | Solid solution of an antifungal agent with enhanced bioavailability | |
| HUP0200281A3 (en) | Heterocyclic benzenesulphonamide compounds as bradykinine antagonists, process for their preparation and pharmaceutical compositions containing them | |
| EP1637142A3 (fr) | Composition stabilisée solide d'un sel d'enalapril et procédé de préparation | |
| MXPA03003533A (es) | Metodo para producir una solucion que consiste en un polimero que contiene unidades azol recurrentes, soluciones producidas de acuerdo con dicho metodo y uso de las mismas. | |
| CA2502582A1 (fr) | Formulation pharmaceutique d'olanzapine | |
| AU2001239625A1 (en) | Method of preparing solid dispersions | |
| AU2003267551A1 (en) | Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone | |
| IL182549A (en) | Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby | |
| AU2566101A (en) | Compounds and methods for the treatment of pain | |
| AU2003233064A1 (en) | Process for the preparation of the amorphous form of atorvastatin calcium salt | |
| YU70502A (sh) | Amorfna modifikacija torasemida | |
| CA2388957A1 (fr) | Derives di-ceto aromatiques, leurs procedes de production et leur utilisation en tant qu'agent pharmaceutique | |
| HUP0200785A3 (en) | Thiazolidinedione derivative and its use as antidiabetic, process for its preparation and pharmaceutical composition containing it | |
| AU2001284189A1 (en) | Modified release formulation |